Results
Ajanta Pharma FY2026 Revenue Up 21%, PAT Rises 18%
Ajanta Pharma reported strong Q4 FY2026 results with revenue up 21% YoY to ₹1,422 crore and PAT up 18% to ₹267 crore.
Full-year consolidated revenue grew 17% to ₹5,453 crore while PAT increased 15% to
